Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet’s disease: multicentre retrospective study

Anti-Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis Refractory to Anti-Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty-Five Patients

(2017) Vanesa Calvo-Río et al.   Arthritis & Rheumatology

Outcome of tocilizumab treatment in refractory ocular inflammatory diseases

(2016) Sukhum Silpa-archa et al.   ACTA OPHTHALMOLOGICA

Advancements in the management of uveitis

(2016) Sergio Schwartzman   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Management of Behçetʼs syndrome

(2016) Yesim Ozguler et al.   CURRENT OPINION IN RHEUMATOLOGY

Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial

(2016) Quan Dong Nguyen et al.   LANCET

Adalimumab in Patients with Active Noninfectious Uveitis

(2016) Glenn J. Jaffe et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy of Anti-IL6-Receptor Tocilizumab in Refractory Cystoid Macular Edema of Birdshot Retinochoroidopathy Report of Two Cases and Literature Review

(2016) Vanesa Calvo-Río et al.   OCULAR IMMUNOLOGY AND INFLAMMATION

Golimumab in refractory uveitis related to spondyloarthritis. Multicenter study of 15 patients

(2016) Vanesa Calvo-Río et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Tocilizumab in severe and refractory Behcet’s disease: Four cases and literature review

(2016) Alban Deroux et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Efficacy and safety profile of anti-interleukin-1 treatment in Behçet’s disease: a multicenter retrospective study

(2015) Giacomo Emmi et al.   CLINICAL RHEUMATOLOGY

Safety of subcutaneous versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis

(2015) Maeve McLaughlin et al.   Expert Opinion On Drug Safety

Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients

(2015) Leyre Riancho-Zarrabeitia et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Tocilizumab for severe refractory neuro-Behçet: Three cases IL-6 blockade in neuro-Behçet

(2015) Olga Addimanda et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients

(2015) Javier Loricera et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Ocular Involvement of Behçet’s Syndrome: a Comprehensive Review

(2014) Yilmaz Ozyazgan et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Paradoxical mucocutaneous flare in a case of Behçet’s disease treated with tocilizumab

(2014) Luca Cantarini et al.   CLINICAL RHEUMATOLOGY

Inhibition of Interleukin-1 by Canakinumab as a Successful Mono-Drug Strategy for the Treatment of Refractory Behçet's Disease: A Case Series

(2014) Antonio Vitale et al.   DERMATOLOGY

A case of Behçet’s disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab

(2014) Toru Hirano et al.   Modern Rheumatology

Anti-TNF-  therapy in patients with refractory uveitis due to Behcet's disease: a 1-year follow-up study of 124 patients

(2014) V. Calvo-Rio et al.   RHEUMATOLOGY

A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy

(2014) Toshio Tanaka et al.   SEMINARS IN IMMUNOLOGY

Efficacy of Tocilizumab in Conventional Treatment-Refractory Adult-Onset Still's Disease: Multicenter Retrospective Open-Label Study of Thirty-Four Patients

(2014) Francisco Ortiz-Sanjuán et al.   Arthritis & Rheumatology

Resistant Behçet Disease Responsive to Anakinra

(2013) Costantino Botsios et al.   ANNALS OF INTERNAL MEDICINE

Anakinra treatment in drug-resistant Behcet’s disease: a case series

(2013) Luca Cantarini et al.   CLINICAL RHEUMATOLOGY

The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria

(2013) et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Expert Panel Recommendations for the Use of Anti–Tumor Necrosis Factor Biologic Agents in Patients with Ocular Inflammatory Disorders

(2013) Grace Levy-Clarke et al.   OPHTHALMOLOGY

Lack of efficacy of tocilizumab in mucocutaneous Behçet’s syndrome: report of two cases

(2013) Andreas P. Diamantopoulos et al.   RHEUMATOLOGY

Epidemiology of Behçet Disease

(2012) Moncef Khairallah et al.   OCULAR IMMUNOLOGY AND INFLAMMATION

Treatment of Refractory Uveitis with Adalimumab: A Prospective Multicenter Study of 131 Patients

(2012) Manuel Díaz-Llopis et al.   OPHTHALMOLOGY

Behçet Disease: Visual Prognosis and Factors Influencing the Development of Visual Loss

(2011) Simon R.J. Taylor et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Tocilizumab treatment for neuro-Behcet's disease, the first report

(2011) Lee S. Shapiro et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

A single infliximab infusion vs corticosteroids for acute panuveitis attacks in Behcet's disease: a comparative 4-week study

(2010) N. Markomichelakis et al.   RHEUMATOLOGY

Anti-TNF Agents for Behçet's Disease: Analysis of Published Data on 369 Patients

(2010) Aikaterini Arida et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM